tetano
Editor, Senior Moderator
Heliyon
. 2023 Oct 12;9(10):e20913.
doi: 10.1016/j.heliyon.2023.e20913. eCollection 2023 Oct. Detection of SARS-CoV-2 omicron variants by immunochromatographic kit
Satoshi Oshiro[SUP] 1 [/SUP], Fuminori Mizukoshi[SUP] 2 [/SUP], Naeko Mizutani[SUP] 1 [/SUP], Makoto Akiwa[SUP] 3 [/SUP], Jun-Ichiro Sekiguchi[SUP] 3 [/SUP], Tatsuya Tada[SUP] 1 [/SUP], Yuki Yamamoto[SUP] 4 [/SUP], Yoko Tabe[SUP] 4 [/SUP], Takashi Miida[SUP] 4 [/SUP], Teruo Kirikae[SUP] 1 [/SUP]
Affiliations
An immunochromatographic kit using antibodies against recombinant N protein of an omicron B.1.1.529 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was developed to detect SARS-CoV-2 omicron variants. The kit detected omicron variants (BA.1.18, BA.1.1, BA.2, BA.2.12.1, BA.2.75, BA.4.1, BA.4.6, BE.1, BA.5.2.1, XE, BF.7, BF.7.4.1, XBB.1, XBB.1.5 and BQ.1.1) as well as Wuhan strain and a delta variant.
Keywords: Immunochromatographic kit; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variants.
. 2023 Oct 12;9(10):e20913.
doi: 10.1016/j.heliyon.2023.e20913. eCollection 2023 Oct. Detection of SARS-CoV-2 omicron variants by immunochromatographic kit
Satoshi Oshiro[SUP] 1 [/SUP], Fuminori Mizukoshi[SUP] 2 [/SUP], Naeko Mizutani[SUP] 1 [/SUP], Makoto Akiwa[SUP] 3 [/SUP], Jun-Ichiro Sekiguchi[SUP] 3 [/SUP], Tatsuya Tada[SUP] 1 [/SUP], Yuki Yamamoto[SUP] 4 [/SUP], Yoko Tabe[SUP] 4 [/SUP], Takashi Miida[SUP] 4 [/SUP], Teruo Kirikae[SUP] 1 [/SUP]
Affiliations
- PMID: 37876437
- PMCID: PMC10590776
- DOI: 10.1016/j.heliyon.2023.e20913
An immunochromatographic kit using antibodies against recombinant N protein of an omicron B.1.1.529 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was developed to detect SARS-CoV-2 omicron variants. The kit detected omicron variants (BA.1.18, BA.1.1, BA.2, BA.2.12.1, BA.2.75, BA.4.1, BA.4.6, BE.1, BA.5.2.1, XE, BF.7, BF.7.4.1, XBB.1, XBB.1.5 and BQ.1.1) as well as Wuhan strain and a delta variant.
Keywords: Immunochromatographic kit; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variants.